Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus.
This is the sixth in a series of CPD articles aimed at reviewing the recent general medical literature relating to topics that may be of interest to dermatologists. In this issue the new classes of anti-retroviral drugs will be described in the context of the replication cycle of human immunodeficiency virus (HIV). The regimens of drug treatments and the more common side-effects including HIV-lipodystrophy syndrome will be discussed along with the recommendations for testing of people for HIV from new guidelines.
Finucane
K A
KA
Bristol Dermatology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. katherine.finucane@nbt.nhs.uk
Archer
C B
CB
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015497:HIV-1; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D017410:Practice Guidelines as Topic; D012307:Risk Factors